Linnea Achieves CEP Certification for Cannabidiol Isolate

Contributed by: Business Wire

Logo

Tags

Other Health

General Health

Other Retail

Cannabis

Pharmaceutical

Other Natural Resources

Natural Resources

Fitness & Nutrition

Cosmetics

Retail

Alternative Medicine

Vitamins/Supplements

Health

Linnea

More Like This

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare

First Cannabis full-spectrum product, manufactured in Brazil by Ease Labs, is approved by the local Health Regulatory Agency

CBD is approved for treatment-resistant epilepsy in children, and recent trials suggest that it may be useful for treating other disorders, such as schizophrenia and anxiety. Photo credit: Julia Zolotova

Quolet announces completion of Phase 1 healthy volunteer study evaluating the safety and bioavailability of Cannabidiol in a novel formulation intended for treatment of various neurological and psychiatric diseases

Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

PR Newswire associated0

AQUALITAS LEADS THE WAY AS THE FIRST ORGANIC CANNABIS PRODUCER IN THE WORLD TO BE ISSUED EU-GMP CERTIFICATION AND A HEALTH CANADA DRUG ESTABLISHMENT LICENSE

Kexing Biopharm made its appearance at CPHI Milan 2024: Launch Ceremony for Apexelsin® in EU market Successfully done